| cilostazol / Generic mfg. |
| Completed | 4 | 244 | RoW | Cilostazol, pletaal, placebo, matching placebo of cilostazol | Asan Medical Center, Korea Otsuka Pharmaceutical Co., Ltd. | Cerebral Infarction | 06/08 | 07/08 | | |
NCT00272454: Cilostazol in Acute Ischemic Stroke Treatment (CAIST) |
|
|
| Completed | 4 | 468 | RoW | Cilostazol, Aspirin | Korea Otsuka Pharmaceutical Co., Ltd., Seoul National University Boramae Hospital, Korea Otsuka International Asia Arab Co., Ltd. | Cerebral Infarction | | 09/08 | | |
ECLIPse, NCT00741286: Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler |
|
|
| Completed | 4 | 203 | RoW | Aspirin, cilostazol, Pletaal | Inje University, Korea Otsuka Pharmaceutical Co., Ltd. | Cerebral Infarction | 10/08 | 10/08 | | |
NCT00234065: Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) |
|
|
| Completed | 4 | 2800 | Japan | Cilostazol, Aspirin | Otsuka Pharmaceutical Co., Ltd. | Cerebral Infarction | 12/08 | 12/08 | | |
| Completed | 4 | 457 | RoW | clopidogrel, Plavix, produced by Sanofi-Aventis., Cilostazol, cilostazol produced by Korea Otsuka Pharmaceutical | Asan Medical Center, Korea Otsuka International Asia Arab | Cerebral Infarction, Atherosclerosis | 01/09 | 01/09 | | |
ACCEL-AMI-2C19, NCT00915733: Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism |
|
|
| Completed | 4 | 80 | RoW | cilostazol, Otsuka brand of cilostazol, clopidogrel (Plavix), Plavix, CYP2C19, Cytochrome 2C19, aspirin (Acetylsalicylic acid), Acetylsalicylic acid | Gyeongsang National University Hospital | Myocardial Infarction | 10/09 | 11/09 | | |
NCT00823875: Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject |
|
|
| Completed | 4 | 200 | RoW | Cilostazol group, Pletaal, Probucol group, Changtai, Cilostazol + Probucol group, Pletaal and Changtai, control group, Routine Treatment | Otsuka Beijing Research Institute | Atherosclerosis Cerebral Infarction | 12/09 | 07/10 | | |
NCT01188824: The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) |
|
|
| Completed | 4 | 801 | RoW | Cilostazol, Pletaal®, placebo | China Medical University Hospital, National Taiwan University Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Tri-Service General Hospital, Far Eastern Memorial Hospital, Changhua Christian Hospital, Chi Mei Medical Hospital, National Cheng-Kung University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, E-DA Hospital, Mackay Memorial Hospital, Cathay General Hospital, En Chu Kong Hospital, Kuang Tien General Hospital, Chung Shan Medical University, Taipei Veterans General Hospital, Taiwan | Ischemic Stroke | 07/13 | 07/13 | | |
NCT01995370: Cilostazol Stroke Prevention Study for Antiplatelet Combination |
|
|
| Completed | 4 | 1884 | Japan | aspirin, Bayaspirin, clopidogrel, Plavix, cilostazol, Pletaal OD Tablet | Japan Cardiovascular Research Foundation, Otsuka Pharmaceutical Co., Ltd. | Noncardioembolic Cerebral Infarction | 12/18 | 12/18 | | |
